Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Tables)

v3.22.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of stock option plans
    Years Ended December 31,  
    2022     2021  
    Number
of Shares
    Weighted Average Exercise Price     Number
of Shares
    Weighted Average
Exercise Price
 
Outstanding at beginning of year     74     $ 3.74       207     $ 4.16  
Options exercised    
     
      (124 )     3.74  
Options expired    
     
      (9 )     12.90  
Outstanding at end of year     74     $ 3.74       74     $ 3.74  
Options exercisable at end of year     74     $ 3.74       74     $ 3.74  

 

Schedule of stock options outstanding
      Options Outstanding     Options Exercisable  
Range of Exercise Prices     Number Outstanding     Weighted-
Average
Remaining
Contractual
Life (yrs.)
    Weighted-
Average
Exercise
Price
    Number
Exercisable
    Weighted-
Average
Exercise
Price
 
                                 
$ 3.74       74       0.46     $ 3.74       74     $ 3.74  

 

Schedule of unvested restricted stock activity
    Number of
Shares
    Weighted-
Average
Grant Date
Fair Value
Per Share
 
Unvested at December 31, 2020     2,260     $ 1.34  
Issued     750     $ 5.76  
Vested     (1,525 )   $ 1.64  
Canceled     (98 )   $ 2.77  
Unvested at December 31, 2021     1,387     $ 3.30  
Issued     872     $ 6.21  
Vested     (1,051 )   $ 2.66  
Canceled     (39 )   $ 6.23  
Unvested at December 31, 2022     1,169     $ 5.95  

 

Schedule of common stock at vesting aggregated
    Years Ended December 31,  
    2022     2021     2020  
Employees   $ 2,689     $ 1,758     $ 2,025  
Non-employees     644       1,125       654  
Total stock-based compensation expense   $ 3,333     $ 2,883     $ 2,679